Standard Glass Lining Technology Ltd

Standard Glass Lining Technology Ltd

₹ 180 -4.86%
11 Jun - close price
About

Incorporated in September 2012, Standard Glass Lining Technology Limited is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India.[1]

Key Points

Business Overview[1] Standard Glass is among the top 5 specialized engineering equipment manufacturers for pharmaceutical and chemical sectors in India (FY24 revenue basis). It provides end-to-end solutions including design, manufacturing, assembly, installation, and commissioning of equipment with over 65+ unique designs and over 11,000 units delivered.

  • Market Cap 3,590 Cr.
  • Current Price 180
  • High / Low 214 / 124
  • Stock P/E 55.8
  • Book Value 35.4
  • Dividend Yield 0.00 %
  • ROCE 16.5 %
  • ROE 11.6 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -12.1%
  • Debtor days have increased from 99.4 to 127 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Mar 2024 Sep 2024 Dec 2024 Mar 2025
138 201 165 140 166
115 170 132 114 143
Operating Profit 23 32 34 26 24
OPM % 17% 16% 20% 19% 14%
0 5 3 3 5
Interest 3 4 4 4 3
Depreciation 3 2 3 3 3
Profit before tax 17 31 29 22 22
Tax % 27% 22% 29% 26% 26%
12 24 21 16 16
EPS in Rs 6.65 12.78 1.07 0.81 0.76
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
240 498 544 614
200 412 449 506
Operating Profit 40 86 95 107
OPM % 17% 17% 17% 18%
1 2 6 12
Interest 4 9 12 15
Depreciation 4 8 9 11
Profit before tax 34 72 80 94
Tax % 26% 26% 25% 27%
25 53 60 69
EPS in Rs 16.44 33.84 32.14 3.23
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 37%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 37%
TTM: 10%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 19%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 15 16 18 199
Reserves 54 140 389 507
70 82 129 68
159 110 129 184
Total Liabilities 298 348 665 958
52 75 96 136
CWIP 1 3 4 8
Investments 0 0 0 0
245 269 565 814
Total Assets 298 348 665 958

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-7 2 -65 5
-30 -29 -157 -160
37 33 232 141
Net Cash Flow 0 5 10 -14

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 125 67 104 127
Inventory Days 399 183 258 296
Days Payable 198 96 102 115
Cash Conversion Cycle 326 154 260 309
Working Capital Days 121 110 256 298
ROCE % 43% 24% 16%

Shareholding Pattern

Numbers in percentages

9 Recently
Mar 2025
60.41%
2.63%
2.21%
34.76%
No. of Shareholders 67,159

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents